Form 4: Molina COO Buys $1.5M in Company Stock

Molina Healthcare's Chief Operating Officer, James Woys, significantly increased his stake in the company by purchasing 10,000 shares of common stock for approximately $1.56 million.

Summary

• James Woys, Chief Operating Officer of Molina Healthcare, Inc. (MOH), acquired 10,000 shares of the company's common stock through two separate transactions.
• On August 4, 2025, Mr. Woys purchased 5,500 shares at a volume-weighted average price of $155.59 per share, with actual prices ranging from $155.00 to $155.98.
• On the same date, he purchased an additional 4,500 shares at a volume-weighted average price of $156.36 per share, with actual prices ranging from $156.01 to $156.94.
• The total value of these purchases amounts to approximately $1,559,755.
• Following these transactions, Mr. Woys beneficially owns a total of 74,331 shares of Molina Healthcare common stock.
• Of the beneficially owned shares, 5,337 shares are scheduled to vest on March 1, 2026; 3,632 shares on March 1, 2027; and 2,082 shares on March 1, 2028. The remaining shares are already vested.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant open market purchase of company stock by a key executive (COO). This action demonstrates strong confidence in the company's future performance and valuation from an insider perspective.

Positives

• The Chief Operating Officer's significant purchase of company stock signals strong confidence in Molina Healthcare's future performance and valuation.
• Insider buying can often be interpreted by the market as a positive indicator, suggesting that management believes the stock is undervalued or expects positive developments.

Future Outlook

The Chief Operating Officer's decision to purchase a substantial amount of company stock suggests a positive internal outlook regarding Molina Healthcare's future prospects and potential for share price appreciation.

Industry Context

In the healthcare sector, insider buying can be a particularly strong signal, as executives often have deep insights into regulatory changes, market dynamics, and competitive landscapes that are not always immediately apparent to external investors. This purchase by a key executive like the COO suggests confidence in Molina Healthcare's strategic positioning and operational execution within the evolving healthcare industry.

Comparison to Industry Standards

• This Form 4 filing reports an insider transaction and does not contain financial results or operational metrics that can be directly compared to industry benchmarks or specific comparable companies' performance. Its primary purpose is to disclose changes in beneficial ownership.

Corporate Governance

Stakeholder Impact

• Shareholders: May view the COO's stock purchase as a positive signal of management's belief in the company's value, potentially boosting investor confidence.
• Employees: Could interpret the insider buying as a sign of stability and positive future outlook for the company.

Next Steps

• Future vesting of 5,337 shares on March 1, 2026.
• Future vesting of 3,632 shares on March 1, 2027.
• Future vesting of 2,082 shares on March 1, 2028.

Key Dates

Recommendation

The significant open market purchase of company stock by the Chief Operating Officer, James Woys, is a strong positive signal. Insiders typically buy shares when they believe the stock is undervalued or expect substantial positive developments. This action suggests high confidence in Molina Healthcare's future performance and strategic direction, making it an attractive signal for potential investors.

Keywords

Molina Healthcare, MOH, James Woys, insider trading, stock purchase, Chief Operating Officer, healthcare, SEC Form 4, beneficial ownership